Clinical Trial Update: Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared single-dose efficacy of a breath-actuated albuterol inhaler with a standard albuterol MDI in participants with asthma; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol HFA MDI (albuterol)
• Albuterol-HFA-BAI (Albuterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2022-08-31